On 3 November 2025, China Longevity Group Company Limited (01863) announced its monthly return for the period ended 31 October 2025. The authorized share capital remained at 2,000,000,000 ordinary shares with a par value of HKD 0.001 each, totaling HKD 2,000,000.
The company stated that the total number of issued shares remained at 852,612,470, with no treasury shares recorded. There were no reported movements in share options, warrants, convertibles, or other share issuance arrangements during the month under review.